Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

D'Ambrosio L;Touati N;Blay JY;Grignani G;Flippot R;Czarnecka AM;Piperno-Neumann S;Martin-Broto J;Sanfilippo R;Katz D;Duffaud F;Vincenzi B;Stark DP;Mazzeo F;Tuchscherer A;Chevreau C;Sherriff J;Estival A;Liti?re S;Sents W;Ray-Coquard I;Tolomeo F;Le Cesne A;Rutkowski P;Stacchiotti S;Kasper B;Gelderblom H;Gronchi A

2020-01-01